A randomized, double-blind, placebo-controlled trial to evaluate the anti-inflammatory efficacy and health benefits of Eleutherococcus senticosus for subjects under renal dialysis with erythropoietin hyporesponsiveness: A pilot study
碩士 === 中山醫學大學 === 營養學系碩士班 === 104 === The main cause for the subjects under renal dialysis with erythropoietin hyporesponsiveness is inflammation which is highly correlated with mortality rates of renal dialysis patients. The Eleutherococcus senticosus (ES) has anti-inflammatory activity confirmed b...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2016
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/hpe98y |